Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Jan;31(3):129-31.
doi: 10.4103/0257-7941.103193.

Skin rash on site of application of Dashanga Lepa (polyherbal formulation): A rare and unexpected drug reaction

Manjunath Ajanal  1 , Avinash Kadam, Shradda U Nayak
Affiliations
Case Reports

Skin rash on site of application of Dashanga Lepa (polyherbal formulation): A rare and unexpected drug reaction

Manjunath Ajanal et al. Anc Sci Life. 2012 Jan.

Abstract

Dashanga Lepa is a polyherbal preparation of Ayurveda, used to treat many skin ailments and rheumatoid arthritis. However, its toxicological property has not been reported so far. We report a rare case of cutaneous adverse reaction in the form of skin rash following the application of Dashanga Lepa. A 42-year-old female patient with a Pittakaphalaprakruthi (constitution) developed skin rashes, soon after the application of Dashanga Lepa over the applied area, which disappeared after stopping the suspected drug and starting treatment with Shatadhauta ghritha. The patient was again treated with the same formulation after a span of a month, which led to the reappearance of a similar type of rash. The temporal relationship, positive dechallenge, and rechallenge are strong associations between the event and formulation. No such reaction was noticed by any other patient with the suspected medicine.

Keywords: Ayurveda; Dashanga Lepa; cutaneous adverse reaction; rheumatoid arthritis; skin rash.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: All the contributors were considered as authors hence we reveal that no potential conflict of interest is there.

References

    1. Sharma SP, editor. Hindi translation. 7th ed. Varanasi: Chaukhambha Amara BharataPrakashana; 1977. “11th Adhyaya. Uttarasthana” Sharangadharasamhita; p. 415.
    1. Vaidhya BG, editor. Hindi translation. Vol. 2. Varanasi: Chaukhambha Bharati Academy; 2005. “547th Drug” NighantuAdarsha; p. 733.
    1. Vasant L. 1st ed. Delhi: Motilal Banarsidass Publishers Private Limited; 1994. Ayurveda the science of self – healing a practical guide; pp. 34–5.
    1. Trikramji AJ, editor. Charaka Samhita. 5th ed. Varanasi: Chaukhambha Sanskri Sansthan; 2006. “21th Adhyaya” Chikitsasthana; p. 564.
    1. Martin T, Li H. Severe cutaneous adverse drug reactions: A review on epidemiology, etiology, clinical manifestation and pathogenesis. Chin Med J (Engl) 2008;121:756–61. - PubMed

Publication types